Teva Pharmaceutical Industries Unveils Teva Rise Innovation Platform

Benzinga · 11/19/2025 13:08

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today unveiled Teva Rise, a global open innovation platform designed to harness the power of a variety of disruptive technologies including AI, industry 4.0 smart manufacturing, digital health and biotech, by connecting startups and technology companies with Teva's business units. The initiative aims to co-create solutions for the challenges faced by the pharmaceutical industry, and to drive patient impact and business transformation in line with Teva's Pivot to Growth strategy.

The launch of Teva Rise comes at a pivotal moment for the pharmaceutical industry, as AI and digital transformation reshape and accelerate drug development, manufacturing, and patient care. By opening its doors to global innovators, Teva is accelerating the adoption of next-generation technologies and strengthening its transformation into a leading biopharmaceutical company. The platform will create access for startups, and tech players around the globe to validate their solutions in real-world settings and enable them to scale their impact across Teva's global ecosystem through partnership model.